AAAAAA

   
Results: 1-13 |
Results: 13
CONCENTRATION-CONTROLLED ZIDOVUDINE THERAPY
Authors: FLETCHER CV ACOSTA EP HENRY K PAGE LM GROSS CR KAWLE SP REMMEL RP ERICE A BALFOUR HH
Citation: Cv. Fletcher et al., CONCENTRATION-CONTROLLED ZIDOVUDINE THERAPY, Clinical pharmacology and therapeutics, 64(3), 1998, pp. 331-338
VALACYCLOVIR
Authors: ACOSTA EP FLETCHER CV
Citation: Ep. Acosta et Cv. Fletcher, VALACYCLOVIR, The Annals of pharmacotherapy, 31(2), 1997, pp. 185-191
PHARMACOKINETICS AND SAFETY OF CONCENTRATION-CONTROLLED ORAL ZIDOVUDINE THERAPY
Authors: ACOSTA EP HENRY K PAGE LM ERICE A BALFOUR HH FLETCHER CV
Citation: Ep. Acosta et al., PHARMACOKINETICS AND SAFETY OF CONCENTRATION-CONTROLLED ORAL ZIDOVUDINE THERAPY, Pharmacotherapy, 17(3), 1997, pp. 424-430
CLINICAL PHARMACOKINETICS OF ZIDOVUDINE - AN UPDATE
Authors: ACOSTA EP PAGE LM FLETCHER CV
Citation: Ep. Acosta et al., CLINICAL PHARMACOKINETICS OF ZIDOVUDINE - AN UPDATE, Clinical pharmacokinetics, 30(4), 1996, pp. 251-262
EFFECT OF FOSCARNET ON QUANTITIES OF CYTOMEGALOVIRUS AND HUMAN-IMMUNODEFICIENCY-VIRUS IN BLOOD OF PERSONS WITH AIDS
Authors: BALFOUR HH FLETCHER CV ERICE A HENRY WK ACOSTA EP SMITH SA HOLM MA BOIVIN G SHEPP DH CRUMPACKER CS EATON CA MARTINMUNLEY SS
Citation: Hh. Balfour et al., EFFECT OF FOSCARNET ON QUANTITIES OF CYTOMEGALOVIRUS AND HUMAN-IMMUNODEFICIENCY-VIRUS IN BLOOD OF PERSONS WITH AIDS, Antimicrobial agents and chemotherapy, 40(12), 1996, pp. 2721-2726
DISPOSITION OF ZIDOVUDINE IN OBESE PREGNANT-WOMEN WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: ACOSTA EP SCHWEBKE K HENRY K FLETCHER CV
Citation: Ep. Acosta et al., DISPOSITION OF ZIDOVUDINE IN OBESE PREGNANT-WOMEN WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 174(3), 1996, pp. 673-673
HEPATOTOXICITY AND RASH ASSOCIATED WITH ZIDOVUDINE AND ZALCITABINE CHEMOPROPHYLAXIS
Authors: HENRY K ACOSTA EP
Citation: K. Henry et Ep. Acosta, HEPATOTOXICITY AND RASH ASSOCIATED WITH ZIDOVUDINE AND ZALCITABINE CHEMOPROPHYLAXIS, Annals of internal medicine, 124(9), 1996, pp. 855-855
PENTAMIDINE CONCENTRATIONS IN A MOTHER WITH AIDS AND IN HER NEONATE
Authors: SCHWEBKE K FLETCHER CV ACOSTA EP HENRY K
Citation: K. Schwebke et al., PENTAMIDINE CONCENTRATIONS IN A MOTHER WITH AIDS AND IN HER NEONATE, Clinical infectious diseases, 20(6), 1995, pp. 1569-1570
ANTIRETROVIRAL DRUG-INTERACTIONS
Authors: ACOSTA EP FLETCHER CV
Citation: Ep. Acosta et Cv. Fletcher, ANTIRETROVIRAL DRUG-INTERACTIONS, International journal of antimicrobial agents, 5(2), 1995, pp. 73-83
GENDER DIFFERENCES IN HUMAN PHARMACOKINETICS AND PHARMACODYNAMICS
Authors: FLETCHER CV ACOSTA EP STRYKOWSKI JM
Citation: Cv. Fletcher et al., GENDER DIFFERENCES IN HUMAN PHARMACOKINETICS AND PHARMACODYNAMICS, Journal of adolescent health, 15(8), 1994, pp. 619-629
AGENTS FOR TREATING HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: ACOSTA EP FLETCHER CV
Citation: Ep. Acosta et Cv. Fletcher, AGENTS FOR TREATING HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, American journal of hospital pharmacy, 51(18), 1994, pp. 2251-2267
LEUKOTRIENE-RECEPTOR ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS IN ASTHMA
Authors: LARSEN JS ACOSTA EP
Citation: Js. Larsen et Ep. Acosta, LEUKOTRIENE-RECEPTOR ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS IN ASTHMA, The Annals of pharmacotherapy, 27(7-8), 1993, pp. 898-903
ADVANCES IN PHARMACOTHERAPY - TREATMENT OF HIV-INFECTION
Authors: FLETCHER CV ACOSTA EP
Citation: Cv. Fletcher et Ep. Acosta, ADVANCES IN PHARMACOTHERAPY - TREATMENT OF HIV-INFECTION, Journal of clinical pharmacy and therapeutics, 18(6), 1993, pp. 375-388
Risultati: 1-13 |